$225.04▲ 0.26 (0.12%)
Real-time prices · US Markets75% of 32 covering analysts have a positive rating.
balance sheet warrants attention.
Quality
5.8
Health
4.3
Growth
5.1
Valuation
6.7
Sentiment
7.7
Analyst Target
$253.55
▲ +12.7% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
109.8×
price-to-earnings
Forward P/E
13.8×
next 12 months est.
Market Cap
$397.6B
market capitalization
Div Yield
3.08%
dividend yield
Profit Margin
5.8%
net profit margin
Gross Margin
72.0%
revenue minus COGS
ROE
—
return on equity
Beta
0.31
vs S&P 500
52-Week Range
$182 — $245
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about AbbVie Inc. right now?
AbbVie Inc.'s Q·Score is 5.8/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. 75% of 32 covering analysts have a positive rating. Key area to monitor: balance sheet warrants attention. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for ABBV?
The consensus price target for ABBV is $253.55, based on ratings from 29 Wall Street analysts. This is 12.7% above the current price of $225.03. Price targets are forward-looking estimates and not guarantees of future performance.
Is ABBV overvalued or undervalued?
AbbVie Inc. (ABBV) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 13.8×. The consensus analyst price target of $253.55 is 13% above the current price.
When does AbbVie Inc. report its next earnings?
AbbVie Inc.'s next earnings report is expected on approximately July 30, 2026.
What is AbbVie Inc.'s profit margin?
AbbVie Inc. has a net profit margin of 5.8%, which is positive but relatively thin. Its gross margin stands at 72.0%, indicating a high-margin business model.
What is ABBV's dividend yield?
AbbVie Inc. currently offers a dividend yield of 3.08%, which is above the typical market average dividend yield. Dividend yields can change based on price movements and company payout decisions.
Is AbbVie Inc.'s revenue growing?
AbbVie Inc. is reporting solid revenue growth of 12.4% year-over-year. However, earnings declined 46.2%, which warrants monitoring.